#Roommates, as more Americans continue to move forward with plans to be fully vaccinated against COVID-19, many were alarmed when the Johnson & Johnson vaccine was recently pulled due to alarming cases of blood clots—but it could be making a return. The Centers For Disease Control recently voted to recommend that the Johnson & Johnson vaccine be reinstated for use and the FDA also has plans to make users aware of its side effects.
@CNN reports, the vaccine advisers from the Centers for Disease Control voted earlier today to recommend officially resuming the use of the Johnson & Johnson COVID-19 vaccine. The vote breakdown was 10 CDC advisers in favor of the recommendation, four advisers opposed and one adviser choosing to abstain from voting. The CDC advisers agreed during their recommendation vote that the benefits of the Johnson & Johnson vaccine outweigh the risks, despite the severe blood clots that have been previously linked to it. In response, an updated warning label from the U.S. Food and Drug Administration will be added to the vaccine stating that women under the age of 50 should be aware of the risk of rare blood clotting syndrome associated with the vaccine.
CDC committee members reportedly worried that deciding to permanently remove one of the three COVID-19 vaccines available would severely slow efforts to ensure that all Americans are vaccinated. Additionally, the recommendation was also influenced by the fact that the Johnson & Johnson vaccine is preferred by many who do not want to take a second dose—as the Johnson & Johnson vaccine only requires one vaccination shot. Now that the advisers have voted, CDC Director Dr. Rochelle Walensky will sign off on ACIP’s recommendation and then FDA will prepare an amended emergency use authorization for the vaccine.
Previously, Johnson & Johnson reportedly agreed to the new FDA warning label acknowledging the risk of thrombosis with thrombocytopenia syndrome, or TTS. According to the CDC, there have been 15 cases of severe blood clots, all in women, with 13 of them occurring in women under the age of 50. Sadly, three of those women have died.
As we previously reported, the Johnson & Johnson COVID-19 vaccine was paused on April 13th and health officials were working behind the scenes to reinstate it as quickly as possible.
Want updates directly in your text inbox? Hit us up at 917-722-8057 or click here to join!